Your reliable CDMO partner
At Rentschler Biopharma, reliability you can trust is more than a promise—it's our commitment. As a global leader in Contract Development and Manufacturing Organization (CDMO) services for biopharmaceuticals, including advanced therapies, we take pride in our contributions to nearly 25% of FDA-approved biopharmaceuticals in 2023.
We offer full-service solutions for bioprocess development and manufacturing of high-quality biopharmaceuticals
Fueled by 50 years of experience in biopharmaceutical manufacturing, we lead the charge in empowering tomorrow's therapies today. Our international state-of-the-art facilities and expert solutions for the most complex biopharmaceuticals ensure excellence at every stage of your product's journey—from concept to market. Our strength lies in our experience with highly complex molecules. Discover how we can support your project.
As a leading Contract Development and Manufacturing Organization (CDMO), we have been carrying out client projects worldwide for decades. Together with our partners, we transform innovative ideas into life-saving biopharmaceuticals – customized solutions that do not stop at the most complex products and processes. Our commitment to quality and reliability is proven worldwide and extends to consulting, project management and regulatory support.
-
Flexibility
We believe that revolutionary ideas come to life when they have the space to develop.
-
Clients
A unique feature of our client dialogue: We are listening.
-
Solutions
Our secret: We find solutions where others do not even look.
-
Performance
Our track record: Security for our clients. Guidepost for our future.
Our Track Record
With more than 50 years of industry experience, we at Rentschler Biopharma are highly qualified experts in the field of biopharmaceuticals. We share your passion for innovation and excellence and set standards in the biopharmaceutical industry.
NEWS
Find out how we are helping to shape the future of biopharmaceuticals. Visit us at the leading industry trade fairs and get to know our team personally. Our news section informs you about the latest developments at our company.
Regulatory compliance is particularly important for US and EU in clinical and commercial stage. Rentschler Biopharma has the knowledge to get into local markets quickly and risk-free.
— Director of a Biopharma company
Careers
As an independent family-owned company, Rentschler Biopharma employs approximately 1,400 people at its headquarters in Laupheim, Germany and a second site in Milford, MA, USA. A third site based in Stevenage, UK, specializes in cell and gene therapies. What unites us is our passion for what we do.
Get in Touch
Contact us now to discuss your needs and find solutions together.